glpg1837
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02325037)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glpg1837
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02707562 | Phase 2 | Feb 1, 2016 | Galapagos NV |
| NCT02690519 | Phase 2 | Jan 1, 2016 | Galapagos NV |
| NCT02562859 | Phase 1 | Sep 1, 2015 | Galapagos NV |
| NCT02562950 | Phase 1 | Sep 1, 2015 | Galapagos NV |
| NCT02325037 | Phase 1 | Dec 1, 2014 | Galapagos NV |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galapagos NV | For profit | 5 | 5 | 2 | 2014 |
1 organizations
Page 1 / 1